Bextra $2.3 Bil. Charge For Pfizer Off-Label Settlement Mars Pre-Wyeth Earnings Report
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer’s proposed $2.3 bil. agreement to resolve Justice Department investigation would be largest pharma settlement ever – not that anyone will notice in context of the $68 bil. Wyeth deal.
You may also be interested in...
Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior
Pfizer's $2.3 billion settlement with the U.S. Department of Justice is unprecedented in size and scope, resolving allegations of off-label marketing of four drugs and kickbacks to health care providers involving nine other drugs. Moreover, the deal includes the largest criminal fine ever imposed by the U.S. government in any matter
Pfizer's Record-Breaking $2.3 Bil. Settlement With U.S. Attorney Imposes New Restrictions on Corporate Behavior
Pfizer's $2.3 billion settlement with the U.S. Department of Justice is unprecedented in size and scope, resolving allegations of off-label marketing of four drugs and kickbacks to health care providers involving nine other drugs. Moreover, the deal includes the largest criminal fine ever imposed by the U.S. government in any matter
Pfizer's Record-Breaking $2.3 Bil. Settlement with DoJ Imposes New Restrictions on Corporate Behavior
A new corporate integrity agreement requires review of sales rep compensation structure, "needs assessment" of publications.